Skip to main content

Inhibitors of NTPDase: Key Players in the Metabolism of Extracellular Purines

  • Chapter
Purine and Pyrimidine Metabolism in Man X

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 486))

Conclusion

This study described the potential of a new class of ATP analogues as NTPDase inhibitors. From previous studies, 8-BuS-ATP appears to be a specific and efficient NTPDase inhibitor.10–11 This novel inhibitor is a new tool to regulate NTPDase activity and thereby influencing purine signalling in mammalian.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beaudoin, A.R., Sévigny, J. and Picher, M. In: Biomembrane, vol. 5; Lee A.G. Ed., Greenwich, CT: JAI, pp. 369–401, 1996.

    Google Scholar 

  2. Beaudoin, A.R. et al. Proceeding of the 2nd International Workshop on ecto-ATPase and related nucleotidases. Diepenbeek, Belgium, 14–18 June 1999. Vanduffel L., and Lemmens R., Eds. Shaker Publishing B.V., The Netherlands; pp. 125–135

    Google Scholar 

  3. Zimmermann, H. et al. Proceeding of the 2nd International Workshop on ecto-ATPase and related nucleotidases. Diepenbeek, Belgium, 14–18 June 1999. Vanduffel L., and Lemmens R., Eds. Shaker Publishing B.V., The Netherlands; pp. 1–8

    Google Scholar 

  4. Vlajkovic, S.M. et al. Neuroreport 9: 1559–1565, 1998.

    CAS  PubMed  Google Scholar 

  5. Vlajkovic, S.M. et al. Mol. Brain Res. 73: 85–92, 1999.

    Article  CAS  PubMed  Google Scholar 

  6. Ziganshin, A.U.; Hoyle, C.H.V.; Burnstock, G. Drug. Dev. Res. 32: 134–146, 1994.

    Article  CAS  Google Scholar 

  7. Picher, M. et al. Biochem. Pharmacol. 51: 1453–1460, 1996.

    Article  CAS  PubMed  Google Scholar 

  8. Bültmann, R. et al. Naunyn-Schmiedeberg’s Arch. Pharmacol. 354: 498–504, 1996.

    Google Scholar 

  9. Crack, B.E. et al. Br. J. Pharmacol. 273: 24814–24821, 1994.

    Google Scholar 

  10. Gendron et al. J. Med. Chem. 43: 2239–2247, 2000

    Article  CAS  PubMed  Google Scholar 

  11. Halbfinger, E. et al. J. Med. Chem. 42: 5325–5337, 1999.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Gendron, F., Halbfinger, E., Fischer, B., Beaudoin, A. (2002). Inhibitors of NTPDase: Key Players in the Metabolism of Extracellular Purines. In: Zoref-Shani, E., Sperling, O. (eds) Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology, vol 486. Springer, Boston, MA. https://doi.org/10.1007/0-306-46843-3_24

Download citation

  • DOI: https://doi.org/10.1007/0-306-46843-3_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46515-4

  • Online ISBN: 978-0-306-46843-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics